SAA1 and COVID-19: While direct SAA binding to COVID-19 patients’ platelets was never tested, these results agree with previous studies showing that serum SAA levels can be used as an inflammation marker and as prognostic markers reflecting COVID-19 severity [15,22,23,24,25,26].